Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine

▴ Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine
An MoU was signed on 5th Nov between the government of Bangladesh, Beximco Pharmaceutical Ltd and the Serum Institute of India for priority delivery of 3 crores COVID-19 vaccine doses.

The process of development of the vaccine is in the final stages at the University of Oxford and AstraZeneca.

Health Minister of Bangladesh Zahid Maleque and High Commissioner of India to Bangladesh Vikram Doraiswami were present on the occasion along with other senior officials of the Health Ministry of Bangladesh and the two companies.

Calling it a ‘landmark agreement’, Health Minister Zahid Maleque expressed the hope that the people of Bangladesh will get relief from this. He said that initially 1.5 crore people will be vaccinated as each person will require two doses of the vaccine.

High Commissioner Vikram Doraiswami said that the vaccine from India was chosen not only because it was the best price but also because it is most suitable for the conditions for the distribution of the vaccine in Bangladesh.

He said that the vaccine is also one of the most promising candidates which are being brought up to the international regulators. The High Commissioner said that it is the culmination of the agenda that Prime Minister Narendra Modi put forward in March this year when he told SAARC leaders that this battle should be fought together and won together.

Meanwhile, new air service between India and Bangladesh under the air-bubble arrangement started yesterday. Welcoming the start of the new service, Bangladesh State Minister for Civil Aviation Md. Mahbub Ali said that the air-bubble arrangement between the two countries has helped people who need to travel for medical, business, and other purposes. He pointed out that Bangladesh and India enjoyed excellent relations and Prime Minister Sheikh Hasina is working to further strengthen people to people ties between the two countries.

Tags : #Bangladesh #India #AstraZeneca #UniversityofOxford #PMNarendraModi #PMSeikhHasina #COVIDvaccine #LatestPharmaNews6thNov

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024
The Future of Healthcare: 10 ways Telehealth is Improving Patient Outcomes and Reducing CostsMay 03, 2024
Understanding the Effects of a Keto Diet on Your Body: A One-Month JourneyMay 03, 2024
High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
Microplastics in Human Brains: Understanding the Emerging Health ConcernMay 03, 2024
Federal Bank Wraps Up FY 24 With 24% Rise in Profit, highest NII, Maintains Robust Asset QualityMay 02, 2024
Two Aveksha Day Care Centers for Construction Workers’ Children opened on the occasion of Labour Day May 02, 2024
AbbVie India and Sightsavers India Collaborate to Raise Awareness on GlaucomaMay 02, 2024
Whither social justice and decent work for women?May 02, 2024
Hyderabad's senior anesthesiologist at the L V Prasad Eye Institute, Dr Raja Narsing Rao elected as President of the World Congress of Ophthalmic AnaesthesiaMay 02, 2024
Navigating Legal Waters: Covishield's Side Effects Prompt Legal Battle from Parents May 02, 2024
Mumps Resurgence in India: Understanding the Recent Outbreak and Prevention StrategiesMay 02, 2024